Familial hypercholesterolaemia: open trials in New Zealand

• NCT07058077

  A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

  Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC

  New Zealand Clinical Research (Christchurch) (Site 1700), Christchurch

  Registry updated 2026-10-07

• NCT07428473

  A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)

  Trial Treatment · Phase 1 · Monash University

  New Zealand Clinical Research (NZCR), Christchurch · Aotearoa Clinical Trials/Middlemore Hospital, Papatoetoe

  Registry updated 2026-09-21

• NCT07491172

  A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

  Trial Treatment · Phase 1 · CRISPR Therapeutics AG

  Aotearoa, Auckland · NZCR, Christchurch

  Registry updated 2026-09-18

• NCT06164730

  A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease

  Trial Treatment · Phase 1 · Verve Therapeutics, Inc.

  Clinical Study Center, Christchurch

  Registry updated 2026-09-02

• NCT07775339

  Long-Term Efficacy and Safety of Lerodalcibep in Children and Adolescents With Familial Hypercholesterolemia

  Trial Treatment · Phase 3 · LIB Therapeutics LLC

  New Zealand Clinical Research, Christchurch

  Registry updated 2026-08-25

• NCT07102511

  Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH

  Trial Treatment · Phase 3 · LIB Therapeutics LLC

  New Zealand Clinical Research, Christchurch

  Registry updated 2026-07-28

• NCT06112327

  Long-term Follow-up of Participants Dosed With an Investigational Gene Editing Therapy for Cardiovascular Disease

  Research · Verve Therapeutics, Inc.

  Clinical Study Center, Auckland · Clinical Study Center, Christchurch

  Registry updated 2026-04-08

All Familial hypercholesterolaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error